THE traditional Indian systems of medicine such as Auyrveda, Unani and Siddha, are facing a threat from an unlikely quarter - the World Trade Organisation's (WTO'S) rules on Intellectual Property
DIVIDING WORKS: Dabur India Ltd plans to spin off its oncology and food divisions into separate companies. Anand Burman, deputy managing director of Dabur India, says, the company now wants to focus
council for Scientific and Industrial Research (csir) and Kottakkal-based Aarya Vaidhya Shala (avs) will jointly develop drug molecules from tradi-tional ayurvedic medicines. This will be the